Worth reading
41Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
1301
¥ million (full-year operating profit forecast revision)Wording
Conditional
How definitive the wording is.Contents of this document
Supplementary materials to the earnings reportSecond quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales79,026 Millions of yen
Operating profit4,410 Millions of yen
Ordinary income4,674 Millions of yen
Net income3,040 Millions of yen
Full-year earnings forecast
Net Sales
167,980 Millions of yen
Operating profit
10,286 Millions of yen
Ordinary income
10,716 Millions of yen
Profit attributable to owners of the parent
6,866 Millions of yen
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The average prescription value is expected to remain above the initial plan, and QLCプロデュース株式会社's results will be consolidated from the third quarterNew initiatives
- Acquisition of shares in QLCプロデュース株式会社 and its consolidation
- 2 absorption-type company splits in the care equipment rental business
- Initiatives to bring service prices into line with appropriate levels
- Withdrawal from unprofitable business locations and stores
Key KPIsA metric the company considers important as a management benchmark.
- Strategic product: inpatient and residential care package sales+8.1% year on yearYear on year against the same period last year+8.1%
- Hotel linen rental revenue+16.6% year on yearYear on year against the same period last year+16.6%
- Direct-to-consumer rental sales of care equipment+5.5% year on yearYear on year against the same period last year+5.5%
- Prescription fee per prescription+5.5% year on yearYear on year against the same period last year+5.5%
- Equity ratio73.2 %Year on year against the same period last year+0.2 percentage points
Unit price and quantity metricsThese figures show sales broken down by price and volume.
An increase in the average prescription value (+5.5%) is indicated, while the combination with volume is Not disclosedSegment results
Health and Lifestyle Services
Net Sales
40,587 Millions of yen
Year on year against the same period last year+5.1%
Operating profit
4,164 Millions of yen
Year-on-year operating profit growth+12.8%
Pharmacy Services
Net Sales
30,922 Millions of yen
Year on year against the same period last year+3.5%
Operating profit
961 Millions of yen
Year-on-year operating profit growth-7.1%
Environmental Services
Net Sales
7,430 Millions of yen
Year on year against the same period last year-0.7%
Operating profit
699 Millions of yen
Year-on-year operating profit growth+9.9%
Other
Net Sales
86 Millions of yen
Year on year against the same period last year-21.8%
Operating profit
-4 Millions of yen
Medium-term management plan targets
Operating profit
9,500 Millions of yen
Financial targets
Equity ratio: 73.2% (actual). Target: Not disclosedCapital expenditures
2,376 Millions of yen
Annual Dividend
Annual dividend per share
89 Yen
Interim Dividend
40 Yen
Year-end dividend
49 Yen
| Item | Details |
|---|---|
| Document type | Supplementary materials to the earnings report |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | 79,026 Millions of yen |
| Operating profit | 4,410 Millions of yen |
| Ordinary income | 4,674 Millions of yen |
| Net income | 3,040 Millions of yen |
| Full-year earnings forecast | Net Sales 167,980 Millions of yen / Operating profit 10,286 Millions of yen / Ordinary income 10,716 Millions of yen / Profit attributable to owners of the parent 6,866 Millions of yen |
| Segment results | Health and Lifestyle Services Net Sales 40,587 Millions of yen / Year on year against the same period last year +5.1% / Operating profit 4,164 Millions of yen / Year-on-year operating profit growth +12.8% / Pharmacy Services Net Sales 30,922 Millions of yen / Year on year against the same period last year +3.5% / Operating profit 961 Millions of yen / Year-on-year operating profit growth -7.1% / Environmental Services Net Sales 7,430 Millions of yen / Year on year against the same period last year -0.7% / Operating profit 699 Millions of yen / Year-on-year operating profit growth +9.9% / Other Net Sales 86 Millions of yen / Year on year against the same period last year -21.8% / Operating profit -4 Millions of yen / Year-on-year operating profit growth Not disclosed |
| Key KPIs | Indicator Strategic product: inpatient and residential care package sales / Value +8.1% year on year / Year on year against the same period last year +8.1%, Indicator Hotel linen rental revenue / Value +16.6% year on year / Year on year against the same period last year +16.6%, Indicator Direct-to-consumer rental sales of care equipment / Value +5.5% year on year / Year on year against the same period last year +5.5%, Indicator Prescription fee per prescription / Value +5.5% year on year / Year on year against the same period last year +5.5%, Indicator Equity ratio / Value 73.2 % / Year on year against the same period last year +0.2 percentage points |
| Unit price and quantity metrics | An increase in the average prescription value (+5.5%) is indicated, while the combination with volume is Not disclosed |
| Assumptions Underlying the Business Outlook | The average prescription value is expected to remain above the initial plan, and QLCプロデュース株式会社's results will be consolidated from the third quarter |
| Medium-term management plan targets | Operating profit 9,500 Millions of yen / Target fiscal year Not disclosed |
| Financial targets | Equity ratio: 73.2% (actual). Target: Not disclosed |
| Annual Dividend | Annual dividend per share 89 Yen / Interim Dividend 40 Yen / Year-end dividend 49 Yen |
| Capital expenditures | 2,376 Millions of yen |
| New initiatives | Acquisition of shares in QLCプロデュース株式会社 and its consolidation, 2 absorption-type company splits in the care equipment rental business, Initiatives to bring service prices into line with appropriate levels, Withdrawal from unprofitable business locations and stores |
Items this document does not state (15)
Gross Profit MarginOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeNumber of stores and locationsNumber of employeesRisk amount incorporated into the outlookPayout ratioAcquisition of treasury sharesOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The reasons are that prescriptions for high-priced medicines and technical fees in the dispensing pharmacy business have exceeded initial expectations, driving up the average prescription value; QLCプロデュース株式会社, which was brought into the group in July 2026, will be consolidated from the third quarter; and operating efficiency for silver materials is expected to improve.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.